Postoperative stenoses of the pulmonary artery vascular system seldom occur alone; they are frequently found in connection with congenital heart defects or malformation syndromes. The resulting increase of afterload represents a serious pressure load for the right ventricle. Depending on the number and severity of the stenoses, gradual functional right ventricular failure is to be expected. Due to limited clinical experience, there has not yet been a consensus concerning the indications for the different therapeutic strategies (balloon dilatation, stent implantation, surgical dilatation techniques). Up to now, only few investigators in few centres use stents as therapy. Therefore, systematic multicenter investigations assessing larger groups of patients undergoing this procedure are not yet available. The same applies to other novel dilatation techniques, such as the use of the "cutting balloon" as therapy for rigid valve stenoses. By comparing and analysing different invasive forms of treatment (balloon dilatation, stent implantation and surgery), we expect to achieve an optimisation of therapy. In the study, the outcomes of different strategies as practiced now in German cardiological centers will be compared and the main factors influencing the results will be determined. On the basis of a standardized investigation before and one year after the intervention, these comparisons with respect to the reduction of stenosis and corresponding changes of right ventricular functional and anatomical changes are carried out correcting for known confounders. The assessment of the different included invasive and non-invasive diagnostical procedures with respect to their ability to detect pathological findings and their changes as result of the treatment is an important secondary target of the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary outcome measure:
To assess the efficacy of the administered therapy, both the ectasia of the stenosed vessels in
relation to the target diameter and the reduction of the pressure gradient in the stenosed vessel
are indicated in percent. An evaluation of the therapeutic success takes place after twelve months.
Definition of the primary target of therapy:
Morphometric:
• Expansion of the peripheral pulmonary artery stenosis to at least 80% of the vascular
lumen.
Manometric:
• Gradient reduction over the stenosis of at least 50%.
• Reduction in right ventricular systolic pressure, indicated by a reduced ratio of systolic
pressure of LV to RV. In this context, there is no definition in terms of a primary target,
as right ventricular pressure reduction depends on a variety of parameters (such as
number of stenoses of the entire peripheral pulmonary vasculature, potential
additional volume load and right ventricular overall function).